Significant Transactions (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Apr. 02, 2021 |
Jun. 30, 2021 |
|
| Viridian Sciences [Member] | ||
| Business Acquisition [Line Items] | ||
| Exchangeable shares issued | $ 6,000 | |
| Cash | 2 | |
| Contingent consideration | $ 6,002 | |
| Ample Organics [Member] | ||
| Business Acquisition [Line Items] | ||
| Exchangeable shares issued | $ 4,650,542 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|